Originally Posted by
43Inches
I would also read the limitations section in that study where they say their findings should be treated with caution. The main issue is that the study does not take into account the habits of each individual post vaccination, so whether the vaccine itself is responsible or such things like how the individual isolated.
You know what else does not take into account the habits of each individual post vaccination, ... or such things like how the individual isolated? Stage III trials.
And do you know where the WHO got the 'efficacy of 63.09% against symptomatic SARS-CoV-2 infection' data from? From AstraZeneca's Stage III trials.
Originally Posted by
43Inches
The WHO data also takes into account generalised effectiveness over a number of different cultures, communities and age groups.
No, not really. It draws that 63.09 percent number exclusively and solely from AstraZeneca's Stage III trial findings.